Cytokeratins expressed in experimental rat bronchial carcinomas

Cytokeratin expression in rat lung tumors was studied using polypeptide‐specific monoclonal antibodies (MAbs) to human cytokeratins 4, 5, 7, 8, 10, 13, 14, 18 and 19. Experiments were performed on tumor fragments derived from 5 experimental rat squamous‐cell lung tumors and one adenocarcinoma, as well as on cell lines obtained from the same tumors. The aims of this study were to investigate the differentiation profile of the rat tumor tissue and established tumor cell lines based on light and electron microscopical features and on cytokeratin phenotype, to characterize the tumor type and degree of differentiation of the lung tumors maintained during passaging in experimental animals, and to compare the cytokeratin expression pattern in transplanted tumors with that of the cultures derived from these tumors. Our results indicate that, in general, the antibodies used cross‐react with rat cytokeratins and that these MAbs can be used to phenotype rat lung carcinomas. Both the tumor fragments and the cultured cells revealed a similar pattern of cytokeratin expression. In addition, the degree of differentiation was maintained upon prolonged culturing in vitro. MAbs to cytokeratin sub‐types can therefore be used to distinguish the main sub‐types of rat lung tumors and can give an indication about the degree of differentiation.

[1]  E. Lane,et al.  Laminin and type VII collagen distribution in different types of human lung carcinoma: correlation with expression of keratins 14, 16, 17 and 18 , 1992, Histopathology.

[2]  Van Bekkum Dw,et al.  Response to chemotherapy of non-small cell bronchial rat tumours growing subcutaneously or in the lung. , 1991 .

[3]  S. Randell,et al.  Properties of rat tracheal epithelial cells separated based on expression of cell surface alpha-galactosyl end groups. , 1991, American journal of respiratory cell and molecular biology.

[4]  S. Wagenaar,et al.  Ultrastructural heterogeneity of lung carcinomas: representativity of samples for electron microscopy in tumor classification. , 1990, Human pathology.

[5]  E. Lane,et al.  Antibody markers of basal cells in complex epithelia. , 1990, Journal of cell science.

[6]  R. Moll,et al.  Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns , 1990, The Journal of cell biology.

[7]  T. Peters,et al.  Cytokeratins in induced epidermoid formations and cholesteatoma lesions. , 1990, Archives of otolaryngology--head & neck surgery.

[8]  S. Wagenaar,et al.  Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies. , 1988, Cancer research.

[9]  D. V. van Bekkum,et al.  Differential behavior of human bronchial carcinoma cells in culture. , 1987, Cancer research.

[10]  F. Ramaekers,et al.  Tissue distribution of keratin 7 as monitored by a monoclonal antibody. , 1987, Experimental cell research.

[11]  T. Smink,et al.  A lung ung cancer model based on intrapulmonary implantation of tumour material , 1986 .

[12]  E. Lane,et al.  Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies. , 1986, Journal of cell science.

[13]  H. Kal,et al.  Induction of lung tumors by radioactive isotopes implanted in the rat lung. , 1986, Journal of the National Cancer Institute.

[14]  E. Lane,et al.  Keratin Antigens in Differentiating Skin , 1985, Annals of the New York Academy of Sciences.

[15]  S. Wagenaar,et al.  Intermediate Filament Proteins in the Study of Tumor Heterogeneity: An In‐Depth Study of Tumors of the Urinary and Respiratory Tracts , 1985, Annals of the New York Academy of Sciences.

[16]  F. Debruyne,et al.  Squamous and transitional elements in rat bladder carcinomas induced by N-butyl-N-4-hydroxybutyl-nitrosamine (BBN). A study of cytokeratin expression. , 1985, The American journal of pathology.

[17]  E. Lane,et al.  Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation , 1985, The British journal of dermatology.

[18]  P. Jap,et al.  Monoclonal antibody to keratin filaments, specific for glandular epithelia and their tumors. Use in surgical pathology. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[19]  P. Jap,et al.  Demonstration of keratin in human adenocarcinomas. , 1983, The American journal of pathology.

[20]  Benjamin Geiger,et al.  The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.

[21]  E. Fuchs,et al.  The expression of keratin genes in epidermis and cultured epidermal cells , 1978, Cell.

[22]  J. J. Broerse,et al.  Experimental radiotherapy of a rat rhabdomyosarcoma with 15 MeV neutrons and 300 kV x-rays. I. Effects of single exposures. , 1969, European journal of cancer.

[23]  D. V. van Bekkum,et al.  Response to chemotherapy of non-small cell bronchial rat tumours growing subcutaneously or in the lung. , 1991, In vivo.

[24]  J. Schalken,et al.  Intermediate filament expression and the progression of prostatic cancer as studied in the dunning R‐3327 rat prostatic carcinoma system , 1989, The Prostate.

[25]  J. Schalken,et al.  Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration , 1988, The Prostate.

[26]  H. Kal,et al.  Development and application of a rat tumor model for human bronchial carcinoma. , 1988, NCI monographs : a publication of the National Cancer Institute.

[27]  D J Ruiter,et al.  Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13. , 1986, Experimental cell research.

[28]  T. Smink,et al.  A rat lung cancer model based on intrapulmonary implantation of tumour material. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.